FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/MEDP
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Medpace Holdings Inc (MEDP) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Medpace (MEDP) trades at $658.24, up 5.75% with strong bullish momentum. The stock shows consistent earnings beats across four consecutive quarters and maintains robust profitability with 17.67% net margins. Technical indicators signal bullish momentum with the current price above key support levels. Recent institutional activity shows mixed sentiment with some firms reducing positions while others increase stakes.
The outlook remains positive given strong earnings performance and projected revenue growth to $2.8B in 2026. However, elevated valuation ratios and CEO stock sales present near-term risks. Analyst consensus leans neutral with 79% hold ratings, though the stock trades above the $620.44 consensus target, suggesting limited upside potential from current levels.
Read full analysis

Key Stats

  • Market Cap
    $18.49B
  • Volume
    1,016,418
  • Sector
    Health
  • 52W High
    $662.48
  • 52W Low
    $393.42
  • Typical Hold Time
    15 Days
  • Enterprise Value
    $17.93B
  • Div Yield
    -
  • Trading Activity
    -
$669.04
52W Low: $393.42
23 Apr 2026
52W High: $669.04
22 Oct 2026

Track Medpace Holdings Inc (MEDP) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Medpace Holdings Inc has traded between a low of $393.42 and a high of $669.04, highlighting its annual price range. Buy and sell Medpace Holdings Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Most Recent News

Content is generated by Aura AI

Mortgage rates drop to 7.32%, easing costs for homebuyers this week.

Freddie Mac reported that the average 30-year fixed mortgage rate fell to 7.32% as of October 22, 2026, down from 7.40% the previous week. This decline offers some relief to prospective homebuyers facing higher borrowing costs compared to last year, ...

Market News
17 minutes ago
Freddie Mac
Neutral
Mortgage rates drop to 7.32%, easing costs for homebuyers this week.

Canada's 5G device market to grow to $15.2B by 2031, driven by spectrum rollout and enterprise IoT demand

Canada's 5G device market is forecasted to expand from USD 10 billion in 2026 to USD 15.2 billion by 2031, growing at 8.7% annually. Growth is fueled by mid-band spectrum deployment, federal connectivity programs, and rising enterprise adoption of ad...

Market News
17 minutes ago
Researchandmarkets.Com
Bullish
news icon
Canada's 5G device market to grow to $15.2B by 2031, driven by spectrum rollout and enterprise IoT demand

Alignment Health adds new Medicare Advantage plan in Pima County for 2027, expanding coverage for Arizona seniors.

Alignment Health Plan will launch a new Medicare Advantage plan in Pima County starting January 1, 2027, increasing access to affordable, coordinated healthcare for nearly 1.1 million Medicare beneficiaries across Maricopa, Pima, and Santa Cruz count...

Market News
1 hour ago
Alignment Health
Bullish
news icon
Alignment Health adds new Medicare Advantage plan in Pima County for 2027, expanding coverage for Arizona seniors.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $18.49B
  • Volume
    1,016,418
  • Sector
    Health
  • 52W High
    $662.48
  • 52W Low
    $393.42
  • Typical Hold Time
    15 Days
  • Enterprise Value
    $17.93B
  • Div Yield
    -
  • Trading Activity
    -
$669.04
52W Low: $393.42
23 Apr 2026
52W High: $669.04
22 Oct 2026

Track Medpace Holdings Inc (MEDP) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Medpace Holdings Inc has traded between a low of $393.42 and a high of $669.04, highlighting its annual price range. Buy and sell Medpace Holdings Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!